Sabine Bleiziffer, Matheus Simonato, John G Webb, Josep Rodés-Cabau, Philippe Pibarot, Ran Kornowski, Stephan Windecker, Magdalena Erlebach, Alison Duncan, Moritz Seiffert, Axel Unbehaun, Christian Frerker, Lars Conzelmann, Harindra Wijeysundera, Won-Keun Kim, Matteo Montorfano, Azeem Latib, Didier Tchetche, Abdelhakim Allali, Mohamed Abdel-Wahab, Katia Orvin, Stefan Stortecky, Henrik Nissen, Andreas Holzamer, Marina Urena, Luca Testa, Marco Agrifoglio, Brian Whisenant, Janarthanan Sathananthan, Massimo Napodano, Antonio Landi, Claudia Fiorina, Armin Zittermann, Verena Veulemans, Jan-Malte Sinning, Francesco Saia, Stephen Brecker, Patrizia Presbitero, Ole De Backer, Lars Søndergaard, Giuseppe Bruschi, Luis Nombela Franco, Anna Sonia Petronio, Marco Barbanti, Alfredo Cerillo, Konstantinos Spargias, Joachim Schofer, Mauricio Cohen, Antonio Muñoz-Garcia, Ariel Finkelstein, Matti Adam, Vicenç Serra, Rui Campante Teles, Didier Champagnac, Alessandro Iadanza, Piotr Chodor, Holger Eggebrecht, Robert Welsh, Adriano Caixeta, Stefano Salizzoni, Antonio Dager, Vincent Auffret, Asim Cheema, Timm Ubben, Marco Ancona, Tanja Rudolph, Jan Gummert, Elaine Tseng, Stephane Noble, Matjaz Bunc, David Roberts, Malek Kass, Anuj Gupta, Martin B Leon, Danny Dvir
AIMS: Due to bioprosthetic valve degeneration, aortic valve-in-valve (ViV) procedures are increasingly performed. There are no data on long-term outcomes after aortic ViV. Our aim was to perform a large-scale assessment of long-term survival and reintervention after aortic ViV. METHODS AND RESULTS: A total of 1006 aortic ViV procedures performed more than 5 years ago [mean age 77.7 ± 9.7 years; 58.8% male; median STS-PROM score 7.3% (4.2-12.0)] were included in the analysis...
August 1, 2020: European Heart Journal